Bispecific Anti-CD28 and Anti-CD22 Antibodies and Their Uses

MA54540AUndetermined Publication Date: 2021-10-27REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA54540
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-12-19
Filing Date
2019-12-18
Publication Date
2021-10-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.